Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing Delta F508-CFTR and G551D-CFTR

摘要

Cystic fibrosis (CF), one of the most common fatal hereditary disorders, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene product is a multidomain adenosine triphosphate-binding cassette (ABC) protein that functions as a chloride (Cl-) channel that is regulated by intracellular magnesium [Mg2+](i). The most common mutations in CFTR are a deletion of a phenylalanine residue at position 508 (Delta F508-CFTR, 70-80 % of CF phenotypes) and a Gly551Asp substitution (G551D-CFTR, 4-5 % of alleles), which lead to decreased or almost abolished Cl- channel function, respectively. Magnesium ions have to be finely regulated within cells for optimal expression and function of CFTR. Therefore, the melastatin-like transient receptor potential cation channel, subfamily M, member 7 (TRPM7), which is responsible for Mg2+ entry, was studies and [Mg2+](i) measured in cells stably expressing wildtype CFTR, and two mutant proteins (Delta F508-CFTR and G551D-CFTR). This study shows for the first time that [Mg2+](i) is decreased in cells expressing Delta F508-CFTR and G551D-CFTR mutated proteins. It was also observed that the expression of the TRPM7 protein is increased; however, membrane localization was altered for both Delta F508del-CFTR and G551D-CFTR. Furthermore, both the function and regulation of the TRPM7 channel regarding Mg2+ is decreased in the cells expressing the mutated CFTR. Ca2+ influx via TRPM7 were also modified in cells expressing a mutated CFTR. Therefore, there appears to be a direct involvement of TRPM7 in CF physiopathology. Finally, we propose that the TRPM7 activator Naltriben is a new potentiator for G551D-CFTR as the function of this mutant increases upon activation of TRPM7 by Naltriben.